Valuation: IRADIMED CORPORATION

Market Cap 1.21B 1.07B 994M 912M 1.71B 116B 1.75B 11.79B 4.61B 57.46B 4.55B 4.45B 199B P/E 2026 *
49.6x
P/E 2027 * 43.8x
Enterprise Value 1.21B 1.07B 994M 912M 1.71B 116B 1.75B 11.79B 4.61B 57.46B 4.55B 4.45B 199B EV / Sales 2026 *
13.3x
EV / Sales 2027 * 12x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.01%
1 week+0.89%
Current month-0.68%
1 month+0.90%
3 months+13.38%
6 months-4.30%
Current year-2.43%
1 week 92.76
Extreme 92.765
97.58
1 month 90.83
Extreme 90.83
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 57.58
Extreme 57.58
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Director/Board Member 73 01/01/2014
Director/Board Member 61 02/09/2025
Director/Board Member 70 01/01/2019
Date Insider Type Main position Quantity % Market Cap.
20/6/26 Fiscal year

Chief Financial Officer

13,911 0.1088%
4/6/26 Sell

Director

-3,000 0.0235%
1/6/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+0.89%+64.21%+116.05% 1.21B
+2.70%-0.47%-17.23%-21.68% 13.44B
+0.07%-8.14%+39.48%-12.31% 3.99B
+1.46%+2.25%-39.18%-59.33% 1.21B
+2.46%+3.43%-38.94%-47.00% 1.1B
+2.86%-2.96%-45.13% - 907M
-0.61%-1.93%+25.62%+80.83% 468M
+0.91%-3.40%+47.03% - 331M
-2.71%-10.44%-62.26%+196.20% 250M
-0.25%-0.75%-33.28%-44.48% 133M
Average +0.69%-1.40%-5.97%+26.04% 2.3B
Weighted average by Cap. +1.86%-0.64%-5.20%-11.11%

Financials

2026 *2027 *
Net sales 91.2M 80.14M 74.8M 68.65M 129M 8.74B 132M 887M 347M 4.32B 342M 335M 14.94B 101M 88.66M 82.76M 75.95M 142M 9.66B 146M 981M 384M 4.78B 379M 371M 16.53B
Net income 24.55M 21.57M 20.14M 18.48M 34.59M 2.35B 35.45M 239M 93.38M 1.16B 92.17M 90.17M 4.02B 27.8M 24.43M 22.8M 20.93M 39.17M 2.66B 40.14M 270M 106M 1.32B 104M 102M 4.56B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
30/07/26 USD 94.91 +0.09% 33,018
28/07/26 USD 94.83 -0.26% 113,775
27/07/26 USD 95.08 +0.62% 67,185
24/07/26 USD 94.49 +0.67% 79,664
23/07/26 USD 93.86 -0.23% 82,772
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
94.83USD
Average target price
118.00USD
Spread / Average Target
+24.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock